Cardiac Dimensions has secured $53m in a Series E funding round to support its ongoing pivotal trial assessing the company’s ...

Cardiac Dimensions announced today that it closed an oversubscribed Series E financing round worth $53 million.

Mitral valve disease is a condition that affects the mitral valve, causing blood to leak backward or flow too slowly, and can lead to serious heart complications, and treatment options include ...

The Duke team performed the world’s first living mitral valve replacement, a type of partial heart transplant, which Duke ...

Partial heart transplants provide a range of lifesaving options for children with complex congenital heart conditions, and can lead to a domino effect of life-saving procedures.

Yale operates first the BATMAN procedure in CT, a less invasive heart treatment offering faster recovery and new hope for ...

At first disturbing, the life-long artist says she transformed the images in her mind to something more peaceful.

Laplace Interventional, a US-based medical device company focusing on transcatheter valve technology, recently announced the ...

Cardiac Dimensions ®, a leader in minimally invasive treatments for heart failure and functional mitral regurgitation (FMR), today announced the close of an oversubscribed $53 million Series E ...